This is an old revision of this page, as edited by Monkbot (talk | contribs) at 19:44, 16 January 2014 (Fix CS1 deprecated date parameter errors). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:44, 16 January 2014 by Monkbot (talk | contribs) (Fix CS1 deprecated date parameter errors)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Dihydroxialumini sodium carbonate is an antacid.
It is also known as "dihydroxyaluminium sodium carbonate".
References
- Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M (March 2000). "Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements". Pharmacol. Toxicol. 86 (3): 135–9. doi:10.1034/j.1600-0773.2000.d01-25.x. PMID 10752672.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
| Drugs for acid related disorders: Antacids (A02A) | |
|---|---|
| Magnesium (increases motility) | |
| Aluminium (decreases motility) | |
| Calcium | |
| Sodium | |
| Combinations and complexes of aluminium, calcium and magnesium | |
 | This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |